These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 15640709)

  • 1. Recent advances in the treatment of infections due to resistant Staphylococcus aureus.
    Anstead GM; Owens AD
    Curr Opin Infect Dis; 2004 Dec; 17(6):549-55. PubMed ID: 15640709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of infections caused by resistant Staphylococcus aureus.
    Anstead GM; Quinones-Nazario G; Lewis JS
    Methods Mol Biol; 2007; 391():227-58. PubMed ID: 18025681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
    Schmidt-Ioanas M; de Roux A; Lode H
    Curr Opin Crit Care; 2005 Oct; 11(5):481-6. PubMed ID: 16175036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Staphylococcus aureus and antibiotic resistance].
    Sancak B
    Mikrobiyol Bul; 2011 Jul; 45(3):565-76. PubMed ID: 21935792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic perspectives of linezolid in the management of infections due to multiresistant Gram-positive pathogens].
    Manfredi R
    Recenti Prog Med; 2007 Mar; 98(3):143-54. PubMed ID: 17484159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with recently approved antibiotics.
    Paterson DL
    Curr Opin Pharmacol; 2006 Oct; 6(5):486-90. PubMed ID: 16904377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and new antimicrobial agents.
    Eliopoulos GM
    Am Heart J; 2004 Apr; 147(4):587-92. PubMed ID: 15077072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New antibiotic agents: problems and prospects.
    Weber DJ; Rutala WA
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-97-107. PubMed ID: 23577500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
    Loffler CA; Macdougall C
    Expert Rev Anti Infect Ther; 2007 Dec; 5(6):961-81. PubMed ID: 18039081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of infections due to resistant Staphylococcus aureus.
    Anstead GM; Cadena J; Javeri H
    Methods Mol Biol; 2014; 1085():259-309. PubMed ID: 24085702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methicillin-resistant Staphylococcus aureus: the superbug.
    Ippolito G; Leone S; Lauria FN; Nicastri E; Wenzel RP
    Int J Infect Dis; 2010 Oct; 14 Suppl 4():S7-11. PubMed ID: 20851011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New treatments for methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Corey GR
    Curr Opin Crit Care; 2009 Oct; 15(5):403-12. PubMed ID: 19561492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: emerging problems and new prospects for management.
    Noskin GA
    Ann Acad Med Singap; 2001 May; 30(3):320-31. PubMed ID: 11455748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New anti-Gram+antibiotics: which role in infective endocarditis?].
    Makinson A; Le Moing V
    Ann Cardiol Angeiol (Paris); 2008 Apr; 57(2):88-92. PubMed ID: 18395180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria.
    Guay DR
    Pharmacotherapy; 2004 Jan; 24(1):58-68. PubMed ID: 14740788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The global prevalence of Daptomycin, Tigecycline, Quinupristin/Dalfopristin, and Linezolid-resistant Staphylococcus aureus and coagulase-negative staphylococci strains: a systematic review and meta-analysis.
    Shariati A; Dadashi M; Chegini Z; van Belkum A; Mirzaii M; Khoramrooz SS; Darban-Sarokhalil D
    Antimicrob Resist Infect Control; 2020 Apr; 9(1):56. PubMed ID: 32321574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging issues in the diagnosis and management of infections caused by multi-drug-resistant, gram-positive cocci.
    Napolitano LM
    Surg Infect (Larchmt); 2005; 6 Suppl 2():S-5-22. PubMed ID: 23577494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of antibiotic susceptibilities and VISA-VRSA rates among MRSA strains isolated from hospitalized patients in intensive care units of hospitals in seven provinces of Turkey].
    Cesur S; Irmak H; Simşek H; Cöplü N; Kılıç H; Arslan U; Bayramoğlu G; Baysan BO; Gülay Z; Hoşoğlu S; Berktaş M; Gencer S; Demiröz AP; Esen B; Karabiber N; Aydın F; Yalçın AN
    Mikrobiyol Bul; 2012 Jul; 46(3):352-8. PubMed ID: 22951647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newer treatment options for skin and soft tissue infections.
    Raghavan M; Linden PK
    Drugs; 2004; 64(15):1621-42. PubMed ID: 15257625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.